ClinConnect ClinConnect Logo
Search / Trial NCT05554835

Global Registry and Natural History Study for Mitochondrial Disorders

Launched by LMU KLINIKUM · Sep 23, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Patient Registry

ClinConnect Summary

The Global Registry and Natural History Study for Mitochondrial Disorders is a research project aimed at understanding various mitochondrial diseases, which are conditions that affect how our cells produce energy. The study will create a worldwide database to gather information from patients with these disorders, making it easier for researchers to learn more about their effects, measure health outcomes, and develop new treatments. This is a chance for patients from all walks of life to contribute to important research that can help improve understanding and care for these complex conditions.

To be eligible for this study, participants should either have a suspected or confirmed mitochondrial disease and be willing to take part in the research. Since the study is open to all ages and genders, many individuals and families may qualify. Participants can expect to share their experiences and health information, which will help researchers gain valuable insights into these diseases. This study is currently recruiting, so it’s a good opportunity for those interested in contributing to the advancement of knowledge in mitochondrial disorders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • suspected or confirmed mitochondrial disease
  • willingness to participate
  • Exclusion Criteria:
  • unwillingness to participate

About Lmu Klinikum

LMU Klinikum is a leading academic medical center affiliated with Ludwig Maximilian University in Munich, Germany. Renowned for its commitment to innovative research and high-quality patient care, LMU Klinikum plays a pivotal role in advancing medical science through clinical trials and translational research. With a multidisciplinary approach, the institution collaborates with various stakeholders, including healthcare professionals, researchers, and industry partners, to facilitate groundbreaking studies that aim to improve therapeutic outcomes and enhance understanding of complex diseases. Its state-of-the-art facilities and expert clinical teams ensure the highest standards of safety and efficacy in clinical research.

Locations

Münster, , Germany

Innsbruck, , Austria

Salzburg, , Austria

Berlin, , Germany

Bonn, , Germany

Düsseldorf, , Germany

Frankfurt Am Main, , Germany

Freiburg, , Germany

Halle/Saale, , Germany

Hamburg, , Germany

Hamburg, , Germany

Hamburg, , Germany

Heidelberg, , Germany

Köln, , Germany

München, , Germany

Reutlingen, , Germany

Tübingen, , Germany

Ulm, , Germany

Pisa, , Italy

Munich, Bavaria, Germany

Patients applied

0 patients applied

Trial Officials

Thomas Klopstock, Prof. Dr.

Principal Investigator

LMU Klinikum, Munich

Michelangelo Mancuso, Prof. Dr.

Principal Investigator

Università di Pisa

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials